OB:AKBMFood
Aker BioMarine (OB:AKBM) Loss Narrows To US$2.8 Million LTM And Tests Bullish Profit Forecasts
Aker BioMarine (OB:AKBM) has wrapped up FY 2025 with fourth quarter revenue of US$55.2 million and a net income loss from continuing operations of US$5.1 million, while discontinued operations added a further loss of US$0.5 million. The company has seen revenue move from US$52 million in Q4 2024 to US$55.2 million in Q4 2025, alongside a shift in quarterly net income from a loss of US$10.9 million in Q4 2024 to a loss of US$5.1 million in Q4 2025. This keeps the spotlight firmly on how...